• Policy
• Handok’s thrombocytopenia drug Doptelet approved in KOR
• by Lee, Hye-Kyung Nov 28, 2024 05:54am

• Policy
• Lagevrio prescription age raised from 60 to 70
• by Kang, Shin-Kook Nov 28, 2024 05:54am

• Policy
• Limiting new drug patent term extensions would be beneficial
• by Lee, Jeong-Hwan Nov 25, 2024 05:53am

• Policy
• Once-weekly Icodec nears approval in Korea
• by Lee, Hye-Kyung Nov 25, 2024 05:53am

• Policy
• Academia requests reimb expansion for Perjeta, Verzenio
• by Lee, Tak-Sun Nov 25, 2024 05:53am

• Policy
• Korea’s 2nd GIFT drug Nefecon is approved in KOR
• by Lee, Hye-Kyung Nov 22, 2024 05:55am

• Policy
• CKD drug Kerendia seeks indication expansion in KOR
• by Lee, Hye-Kyung Nov 21, 2024 05:46am

• Policy
• Strengthed regulations on human drug use in vet clinics
• by Lee, Jeong-Hwan Nov 20, 2024 06:08am

• Policy
• Stelara biosimilars face increasing competition
• by Lee, Tak-Sun Nov 20, 2024 06:08am

• Policy
• Samil voluntarily cuts price of its Vemlino to lowest price
• by Lee, Tak-Sun Nov 19, 2024 06:13am